|
|
Prepublished online as a Blood First Edition Paper on May 24, 2002; DOI 10.1182/blood-2002-02-0418.

Submitted February 8, 2002
Accepted May 6, 2002
Disruption of the long-range GPIIIa Cys5-Cys435 disulfide bond results in the production of constitutively active GPIIb-IIIa ( IIbß3) integrin complexes
Qi-Hong Sun*, Chao-Yan Liu, Ronggang Wang, Cathy Paddock, and Peter J Newman
Blood Research Institute, The Blood Center of Southeastern Wisconsin, Milwaukee, WI, USA; Cardiovascular Center, The Medical College of Wisconsin, Milwaukee, WI, USA
Blood Research Institute, The Blood Center of Southeastern Wisconsin, Milwaukee, WI, USA
Blood Research Institute, The Blood Center of Southeastern Wisconsin, Milwaukee, WI, USA; Departments of Cellular Biology and Pharmacology, The Medical College of Wisconsin, Milwaukee, WI, USA
* Corresponding author; email: qsun{at}bcsew.edu.
The major platelet integrin IIbß3, also known as the platelet glycoprotein (GP) IIb-IIIa complex, mediates platelet aggregation by serving as the receptor for fibrinogen and von Willebrand factor. In addition to its physiologic role, GPIIb-IIIa also bears a number of clinically important alloantigenic determinants. Previous studies have shown that disruption of the long-range Cys5-Cys435 disulfide bond of the ß3 subunit results in the production of GPIIIa isoforms that bind some, but not all, anti-PlA1 alloantibodies, suggesting that mutations in this so-called long-range disulfide bond can alter the conformation of GPIIIa. The purpose of this study was to examine the effect of either the Cys5Ala or Cys435Ala substitution of GPIIIa on the adhesive properties of the GPIIb-IIIa complex. We found that both Ala5GPIIIa and Ala435GPIIIa were capable of associating with GPIIb and were expressed normally on the cell surface when co-transfected into Chinese Hamster Ovary (CHO) cells. CHO cells expressing GPIIb-Ala5GPIIIa or GPIIb-Ala435IIIa bound well-characterized, conformationally-sensitive LIBS (ligand-induced binding site) antibodies, and were capable of constitutively binding the fibrinogen-mimetic monoclonal antibodies PL-55 and PAC-1, as well as soluble fibrinogen. Both GPIIb-Ala5IIIa and GPIIb-Ala435IIIa-transfected CHO cells also bound more avidly to immobilized fibrinogen, and were capable of mediating the tyrosine phosphorylation of pp125FAK upon cell adhesion. These data are consistent with the notion that these regions of GPIIIa participate in the conformational change associated with receptor activation. Additionally, these studies may provide a molecular explanation for the previously reported ability of mild reducing agents to activate the GPIIb-IIIa complex and promote platelet aggregation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Kannan and R. Saxena
Glanzmann's Thrombasthenia: An Overview
Clinical and Applied Thrombosis/Hemostasis,
April 1, 2009;
15(2):
152 - 165.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Bunch, T. L. Helsten, T. L. Kendall, N. Shirahatti, D. Mahadevan, S. J. Shattil, and D. L. Brower
Amino Acid Changes in Drosophila {alpha}PS2betaPS Integrins That Affect Ligand Affinity
J. Biol. Chem.,
February 24, 2006;
281(8):
5050 - 5057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Glerup, H. B. Boldt, M. T. Overgaard, L. Sottrup-Jensen, L. C. Giudice, and C. Oxvig
Proteinase Inhibition by Proform of Eosinophil Major Basic Protein (pro-MBP) Is a Multistep Process of Intra- and Intermolecular Disulfide Rearrangements
J. Biol. Chem.,
March 18, 2005;
280(11):
9823 - 9832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Mould, M. A. Travis, S. J. Barton, J. A. Hamilton, J. A. Askari, S. E. Craig, P. R. MacDonald, R. A. Kammerer, P. A. Buckley, and M. J. Humphries
Evidence That Monoclonal Antibodies Directed against the Integrin {beta} Subunit Plexin/Semaphorin/Integrin Domain Stimulate Function by Inducing Receptor Extension
J. Biol. Chem.,
February 11, 2005;
280(6):
4238 - 4246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Raymond, E. Gorbunova, I. N. Gavrilovskaya, and E. R. Mackow
Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent {alpha}v{beta}3 integrin conformers
PNAS,
January 25, 2005;
102(4):
1163 - 1168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Xiong, T. Stehle, S. L. Goodman, and M. A. Arnaout
A Novel Adaptation of the Integrin PSI Domain Revealed from Its Crystal Structure
J. Biol. Chem.,
September 24, 2004;
279(39):
40252 - 40254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Calvete
Structures of Integrin Domains and Concerted Conformational Changes in the Bidirectional Signaling Mechanism of {alpha}IIb{beta}3
Experimental Biology and Medicine,
September 1, 2004;
229(8):
732 - 744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Jannuzi, T. A. Bunch, R. F. West, and D. L. Brower
Identification of Integrin {beta} Subunit Mutations that Alter Heterodimer Function In Situ
Mol. Biol. Cell,
August 1, 2004;
15(8):
3829 - 3840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chigaev, G. J. Zwartz, T. Buranda, B. S. Edwards, E. R. Prossnitz, and L. A. Sklar
Conformational Regulation of {alpha}4{beta}1-Integrin Affinity by Reducing Agents: "INSIDE-OUT" SIGNALING IS INDEPENDENT OF AND ADDITIVE TO REDUCTION-REGULATED INTEGRIN ACTIVATION
J. Biol. Chem.,
July 30, 2004;
279(31):
32435 - 32443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Butta, E. G. Arias-Salgado, C. Gonzalez-Manchon, M. Ferrer, S. Larrucea, M. S. Ayuso, and R. Parrilla
Disruption of the {beta}3 663-687 disulfide bridge confers constitutive activity to {beta}3 integrins
Blood,
October 1, 2003;
102(7):
2491 - 2497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Quinn, T. V. Byzova, J. Qin, E. J. Topol, and E. F. Plow
Integrin {alpha}IIb{beta}3 and Its Antagonism
Arterioscler Thromb Vasc Biol,
June 1, 2003;
23(6):
945 - 952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Buensuceso, M. de Virgilio, and S. J. Shattil
Detection of Integrin alpha IIbbeta 3 Clustering in Living Cells
J. Biol. Chem.,
April 18, 2003;
278(17):
15217 - 15224.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|